RIP/Rab Activators encompasses a group of compounds that exert their effects on cellular processes through the modulation of Arf GTPase activity, particularly focusing on the activation of RIP (ArfGAP with FG repeats 1) or Rab proteins. Arf GTPases are crucial regulators of vesicular trafficking and membrane dynamics within eukaryotic cells. The activation of RIP, a member of the ArfGAP family, is intricately involved in the regulation of vesicle formation and transport. In this context, RIP/Rab Activators operate by influencing the activation state of Arf GTPases, either directly or indirectly.
Direct RIP/Rab Activators often interact with the guanine nucleotide-binding site of Arf GTPases, promoting the exchange of GDP for GTP. This transition to the GTP-bound state leads to the activation of Arf GTPases, consequently impacting downstream cellular processes modulated by these regulatory proteins. Additionally, compounds classified as RIP/Rab Activators may indirectly influence Arf GTPase activation by targeting upstream regulators, such as guanine nucleotide exchange factors (GEFs) or other proteins involved in Arf GTPase regulation. By enhancing the activation of RIP or Rab proteins, these compounds contribute to the modulation of vesicular trafficking, endocytosis, and membrane dynamics. Understanding the molecular mechanisms by which RIP/Rab Activators operate provides valuable insights into the intricate regulation of cellular transport processes and offers potential avenues for further research into the broader cellular implications of Arf GTPase activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits the Sec7 domain, a GEF for Arf GTPases, indirectly enhancing the activation of RIP/Rab (AGFG1). | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Inhibits Arf activation, impacting vesicular trafficking and indirectly promoting the activation of RIP/Rab (AGFG1). | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Disrupts vesicular transport, indirectly fostering the activation of RIP/Rab (AGFG1). | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibitor of nuclear export, potentially stimulating the nucleocytoplasmic transport and activation of RIP/Rab (AGFG1). | ||||||
(+)-Nutlin-3 | 675576-97-3 | sc-222085 sc-222085A | 500 µg 1 mg | $94.00 $122.00 | ||
Inhibits MDM2-p53 interaction, indirectly enhancing signaling pathways that may activate RIP/Rab (AGFG1). | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Acts as an antioxidant and precursor to glutathione, potentially modulating redox signaling and indirectly promoting the activation of RIP/Rab (AGFG1). | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Inhibitor of dynamin, affecting endocytosis, and indirectly promoting the activation of RIP/Rab (AGFG1). | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Disrupts lipid rafts by cholesterol extraction, potentially impacting the association of RIP/Rab (AGFG1) with lipid rafts and promoting its activation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, potentially influencing the proteolytic regulation of RIP/Rab (AGFG1) and indirectly promoting its stability or activity. | ||||||